Assistant Professor of Oncology, Johns Hopkins University School of Medicine
Hematology
Dr. Josh D. Lauring, MD
Josh Lauring practices Hematology. He researched medicine at Johns Hopkins University School of Medicine. Johns Hopkins University School of Medicine is a top medical university. Johns Hopkins University School of Medicine is ranked 3/29 in Research/PrimaryCare. Josh Lauring is a published doctor. He has 19 papers published. The most current publication "HER2 missense mutations have distinct effects on oncogenic signaling and migration." He accepts Medicare payments and is listed with Medicare.gov.
Publications
- ESR1 mutations in circulating plasma tumor DNA from metastatic breast Cancer patients.
- HER2 missense mutations have distinct effects on oncogenic signaling and migration.
- MACROD2 overexpression mediates estrogen independent growth and tamoxifen resistance in breast Cancers.
- PIK3CA and AKT1 Mutations Have Distinct Effects on Sensitivity to Targeted Pathway Inhibitors in an Isogenic Luminal Breast Cancer Model System.
- Functional analysis of non-hotspot AKT1 mutants found in human breast Cancers identifies novel driver mutations: implications for personalized medicine.
- PIK3CA mutations and EGFR overexpression predict for lithium sensitivity in human Breast epithelial cells.
- Knock in of the AKT1 E17K mutation in human Breast epithelial cells does not recapitulate oncogenic PIK3CA mutations.
- Knockin of mutant PIK3CA activates multiple oncogenic pathways.
- Tamoxifen-stimulated growth of breast Cancer due to p21 loss.
- A PCR-based high-throughput screen with multiround sample pooling: application to somatic cell gene targeting.
- The multiple myeloma associated MMSET gene contributes to cellular adhesion, clonogenic growth, and tumorigenicity.
- Knock-in of mutant K-ras in nontumorigenic human epithelial cells as a new model for studying K-ras mediated transformation.
- A conserved transcriptional enhancer regulates RAG gene expression in developing B cells.
- c-Myb binds to a sequence in the proximal region of the RAG-2 promoter and is essential for promoter activity in T-lineage cells.
- Distinct factors regulate the murine RAG-2 promoter in B- and T-cell lines.
- NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.
- BEAMing sheds light on drug resistance.
- Mutation of a single allele of the Cancer susceptibility gene BRCA1 leads to genomic instability in human breast epithelial cells.
Schools
Johns Hopkins University School Of Medicine
Procedures Preformed
- Thoracentesis
Conditions Treated
- Adrenal Gland Cancer
- Anal and Rectal Cancer
- Anemia
- Bile Duct Cancer
- View All
Doctors Specialties
- Medical Oncology
- Oncology
- Hematology
Accepted Insurances
Education
-
Johns Hopkins University -
Johns Hopkins University School of Medicine
Hospital
-
Johns Hopkins Hospital -
Johns Hopkins Bayview Medical Center
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1710033402 |
| Last Name Of The Provider | LAURING |
| First Name Of The Provider | JOSH |
| View All |
Similar Doctors
|
Dr. Katherine H. Tkaczuk, MD
 This Doctor is OpenDoctor Recommended.
 This doctor has more publications
|
|
|
Dr. Mahsa M. Mohebtash, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Ting Bao, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kevin J. Cullen, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Christopher A. Klebanoff, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Meyer R. Heyman, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Hans J. Hammers, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Dan P. Zandberg, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Charles S. Hesdorffer, MD
This Doctor is OpenDoctor Recommended.
This doctor has more publications
|
|
|
Dr. Milena Vuica-Ross, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Leo Luznik, MD |
|
|
Dr. Lois K. Kamugisha, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. V G. Nelson, MD |